发明人罗永刚,赵玉洁,黄志刚. "一种乌帕替尼杂质151的合成方法" [P]. 中国发明专利, 专利号 CN 108891579 A, 授权公告日 2021-04-27.
O'Brien P Q, Davis P L, Schröder R. "Method for the Synthesis of Upadacitinib Impurity 151" [P]. US Patent, US 11315884 B2, 2019-08-22.
发明人郭海燕,韩伟,钱学锋. "A Process for Preparing High-Purity Upadacitinib Impurity 151" [P]. 中国发明专利, 专利号 CN 109341168 A, 授权公告日 2017-09-09.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质151 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 197, (2), 4655-4667.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质151 as an Impurity". Anal. Chim. Acta, 2011, 872, (4), 2241-2263.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 151 Using HRMS and NMR". J. Nat. Prod., 2010, 1239, (5), 851-858.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 乌帕替尼杂质151 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2012, 1700, 9806-9817.